Evidence map›Paper›PMID 40980679›Full record

ArticleKidney international reports2025

A Comprehensive Framework for Kidney Function Assessment: Summary of the National Institute of Diabetes and Digestive and Kidney Diseases Reimagining Kidney Function Assessment Workshop.

Petter Bjornstad, Phoom Narongkiatikhun, Thomas Benzing, Dana Y Fuhrman, Lesley Inker, Bryan Kestenbaum, Jay Koyner, Kevin Lemley, Jesse Seegmiller, Sushrut S Waikar

Abstract read
In one paragraph

Article in Kidney international reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Petter BjornstadDivision of Endocrinology, Metabolism and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
Phoom NarongkiatikhunDivision of Endocrinology, Metabolism and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
Thomas BenzingDepartment II of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Dana Y FuhrmanDivision of Nephrology, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Lesley InkerDivision of Nephrology, Department of Medicine, Tufts Medical Center, Boston, Massachusetts, USA.
Bryan KestenbaumDivision of Nephrology, Kidney Research Institute, University of Washington, Seattle, Washington, USA.
Jay KoynerSection of Nephrology, Department of Medicine, University of Chicago, Chicago, Illinois, USA.
Kevin LemleyDivision of Nephrology, Children's Hospital Los Angeles, Los Angeles, California, USA.
Jesse SeegmillerDepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA.
Sushrut S WaikarSection of Nephrology, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current kidney function assessment primarily relies on estimation of glomerular filtration rate (GFR), which fails to capture the full spectrum of kidney functions and may limit accurate disease classification and targeted treatments. To propose innovative strategies to comprehensively assess kidney functions, aiming to improve our capacity to uncover pathophysiologic mechanisms and delineate novel disease subgroups, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) convened a workshop titled "Re-imagining Kidney Function Assessment." This workshop brought together experts to discuss current limitations and potential advancements in kidney function evaluation. Key themes emerged, including the following: (i) the need for standardized protocols for measured GFR using exogenous filtration markers, (ii) the potential of kidney functional reserve (KFR) and stress tests to reveal subclinical kidney dysfunction, (iii) the importance of assessing tubular secretion alongside glomerular filtration, (iv) the value of glomerular permselectivity measurements in predicting disease progression; and (v) the promise of integrating molecular profiling with functional assessments for precision medicine in nephrology. The workshop highlighted the critical need for a more comprehensive approach to kidney function assessment. Integrating diverse kidney function measures into tailored, individual-level assessments could lead to more accurate disease classification, targeted interventions, ability to track response to therapies, and improved patient outcomes. Future research should focus on developing and validating these novel assessment strategies to advance precision medicine in nephrology.

Identifiers

PMID40980679
PMCPMC12446987

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.